Literature DB >> 11121622

Anhydride modified cantharidin analogues. Is ring opening important in the inhibition of protein phosphatase 2A?

A McCuskey, M A Keane, L M Mudgee, A T Sim, J Sakoff, R J Quinn.   

Abstract

A series of anhydride modified cantharidin analogues have been synthesised and screened for their ability to inhibit protein phosphatase 2A. Surprisingly only analogues capable of undergoing a facile ring opening of the anhydride moiety displayed any significant inhibition. Subsequent NMR experiments indicated that 7-oxobicyclo[2.2.1]heptane-2,3-dicarboxylic acid was the major (sole) species under assay conditions. The ability of these modified anhydro-cantharidin analogues to inhibit protein phosphatase 2A varies from 4 (16) to 100% (8) at 100 microM test concentration.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11121622     DOI: 10.1016/s0223-5234(00)00186-0

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  4 in total

1.  Anticancer activity and protein phosphatase 1 and 2A inhibition of a new generation of cantharidin analogues.

Authors:  Jennette A Sakoff; Stephen P Ackland; Monique L Baldwin; Mirella A Keane; Adam McCluskey
Journal:  Invest New Drugs       Date:  2002-02       Impact factor: 3.850

2.  Synthesis of a polymerizable, bivalent glycan mimetic of the HIV envelope spike gp120.

Authors:  Eric T Sletten; Riley L Svec; Hien M Nguyen
Journal:  Tetrahedron Lett       Date:  2015-06-03       Impact factor: 2.415

3.  A simple route to a novel acid-sensitive 20(S)-O-linked camptothecin norcantharidin acid ester derivative.

Authors:  Changkuo Zhao; Xianheng Wang; Fuhong Yang; Lei Gao; Yuhe Wang
Journal:  R Soc Open Sci       Date:  2018-02-14       Impact factor: 2.963

4.  The regio-selective synthesis of 10-hydroxy camptothecin norcantharidin conjugates and their biological activity evaluation in vitro.

Authors:  Chang K Zhao; Chan Li; Xian H Wang; Yu J Bao; Fu H Yang; Mei Huang
Journal:  R Soc Open Sci       Date:  2018-06-13       Impact factor: 2.963

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.